J&J Preps Experimental Ebola Vaccine for May Trial

The transcript covers three main topics: Jeffrey Foul's release from North Korea with Sweden's help, Heineken's third-quarter financial results and challenges, and Johnson & Johnson's efforts in developing an Ebola vaccine. The US continues to press North Korea for the release of two other Americans. Heineken faces sluggish sales growth due to a volatile global environment and poor weather. Johnson & Johnson plans to have 250,000 doses of an experimental Ebola vaccine ready for clinical trials, with a goal of producing 1 million doses next year.

What was the outcome of Foul's detention this summer?

How many people have been killed by Ebola, according to the text?